AEGiS-UPI: HEALTH BRIEFS: HIV Takes a Ride United Press InternationalImportant note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




HEALTH BRIEFS: HIV Takes a Ride

United Press International - November 20, 2001
Lidia Wasowicz, UPI Senior Science Writer


The AIDS virus HIV must attach itself to cholesterol-rich regions of a cell's membrane before it can do its dirty deed, researchers have found. The scientists at the National Institute of Allergy and Infectious Diseases in Bethesda, Md., removed cholesterol from cells and found the virus lost much of its punch, slowing its reproduction and its infection of new cells. The discovery provides a clearer roadmap of HIV's travels into and out of cells -- and a possible means of obstructing that ride, the investigators said. "Our research raises the intriguing possibility that widely used cholesterol-lowering drugs might have an effect in humans similar to what we have found in these initial laboratory studies," said Eric Freed, investigator in NIAID's Laboratory of Molecular Microbiology and senior author of the paper published in the journal Proceedings of the National Academy of Sciences. As it enters or exits a cell, HIV must navigate the complex double-walled outer membrane which contains a mix of solid and fluid areas. Here can be found small, cholesterol-rich patches, called rafts for their ability to move like a raft on water. Rafts are thought to be most concentrated at points of cell-to-cell contact in the immune cells targeted by HIV. Any mechanism that helps HIV find and attach to rafts would help the virus spread. Conversely, even a little disruption could slow the virus's spread by hindering its ability to enter and leave cells, Freed said.


011120
UP011111


Copyright © 2001 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .